Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
Year |
Ref. |
Project |
Sample 15/16 y.o. |
LTP all |
LTP male |
LTP female |
LYP |
LMP | |
---|---|---|---|---|---|---|---|---|---|---|
Belgium (Flemish) |
|
2002-2003 |
7 |
VAD |
512 |
24 |
27 |
21 |
15 |
|
Belgium |
|
2003 |
|
ESPAD |
2320 |
32 |
37 |
28 |
27 |
17 |
Czech Republic |
|
2003 |
|
ESPAD |
3195 |
44 |
48 |
40 |
36 |
19 |
Denmark |
|
2003 |
|
ESPAD |
2978 |
23 |
27 |
18 |
17 |
8 |
Germany |
(b) |
2003 |
|
ESPAD |
5110 |
27 |
31 |
24 |
21 |
12 |
Estonia |
|
2003 |
|
ESPAD |
2463 |
23 |
28 |
18 |
14 |
6 |
Greece |
|
2003 |
|
ESPAD |
1906 |
6 |
7 |
5 |
5 |
2 |
France |
|
2003 |
|
ESPAD |
2199 |
38 |
42 |
35 |
31 |
22 |
Ireland |
|
2003 |
|
ESPAD |
2407 |
39 |
38 |
39 |
31 |
17 |
Italy |
|
2003 |
|
ESPAD |
4871 |
27 |
31 |
23 |
22 |
15 |
Cyprus |
|
2003 |
|
ESPAD |
2152 |
4 |
7 |
2 |
3 |
2 |
Latvia |
|
2003 |
|
ESPAD |
2841 |
16 |
20 |
12 |
9 |
4 |
Lithuania |
|
2003 |
|
ESPAD |
5036 |
13 |
18 |
9 |
11 |
6 |
Hungary |
|
2003 |
|
ESPAD |
2677 |
16 |
18 |
13 |
11 |
6 |
Netherlands |
|
2003 |
|
ESPAD |
2095 |
28 |
32 |
24 |
23 |
13 |
Malta |
|
2003 |
|
ESPAD |
3500 |
10 |
13 |
8 |
9 |
4 |
Austria |
|
2003 |
|
ESPAD |
2402 |
21 |
23 |
18 |
17 |
10 |
Poland |
|
2003 |
|
ESPAD |
5964 |
18 |
23 |
13 |
14 |
8 |
Portugal |
|
2003 |
|
ESPAD |
2946 |
15 |
18 |
12 |
13 |
8 |
Slovenia |
|
2003 |
|
ESPAD |
2785 |
28 |
31 |
26 |
23 |
14 |
Slovakia |
|
2003 |
|
ESPAD |
2276 |
27 |
32 |
22 |
20 |
10 |
Finland |
|
2003 |
|
ESPAD |
3543 |
11 |
11 |
11 |
8 |
3 |
Sweden |
(c) |
2003 |
8 |
CAN |
approx. 5000 |
6 |
6 |
6 |
|
2 |
Sweden |
|
2003 |
|
ESPAD |
3232 |
7 |
9 |
6 |
5 |
1 |
United Kingdom |
|
2003 |
|
ESPAD |
2068 |
38 |
41 |
35 |
31 |
20 |
Bulgaria |
|
2003 |
|
ESPAD |
2740 |
21 |
23 |
19 |
16 |
8 |
Romania |
|
2003 |
|
ESPAD |
4371 |
3 |
4 |
2 |
2 |
0 |
Turkey |
(b) |
2003 |
|
ESPAD |
4177 |
4 |
6 |
2 |
5 |
3 |
Norway |
|
2003 |
|
ESPAD |
3833 |
9 |
9 |
9 |
6 |
3 |
Notes: This table aims to present data on 15- to 16-year-old school students obtained from national surveys. The surveys for Belgium (Flemish) is the Flemish region only and the Germany ESPAD is limited to the regions specified in note (b). In all of the school surveys the method for data collection was classroom based, anonymous, self-completion questionnaires in written test conditions. Caution is required comparing figures due to methodological limitations. For methods and definitions see [Methods and definitions - schools surveys]. ESPAD ESPAD (The European School Survey Project on Alcohol and Other Drugs) 1995 and 1999 is co-ordinated by The Swedish Council for Information on Alcohol and Other Drugs. (CAN) and Council of Europe (Pompidou Group). ESPAD prevalence figures are reported rounded to the nearest whole percentage point (other sources supply percentages up to one decimal place, which have been rounded off for use in this table). The sample sizes given for 15/16 y.o. refer to the number of participating students who filled in the questionnaire. For further details see http://www.espad.org. (b) ESPAD 2003 Germany figures are based in six regions only (Bavaria, Brandenburg, Berlin, Hesse, Mecklenburg-Western Pomerania and Thuringia. Turkey figures are based on one major city in each of 6 different regions (Adana, Ankara, Diyarbakir, Istanbul, Izmir and Samsun). (c) ESPAD methods are adopted to varying degrees. Sources: See [Table EYE-0] |